.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Dow
McKinsey
Chinese Patent Office
Covington
Harvard Business School
Teva
Accenture
Julphar
Novartis

Generated: July 27, 2017

DrugPatentWatch Database Preview

ERYPED Drug Profile

« Back to Dashboard

Which patents cover Eryped, and what generic Eryped alternatives are available?

Eryped is a drug marketed by Arbor Pharms Llc and Arbor Pharms Inc and is included in two NDAs.

The generic ingredient in ERYPED is erythromycin ethylsuccinate. There are ninety-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for Tradename: ERYPED

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list21
Clinical Trials: see list1
Patent Applications: see list540
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYPED at DailyMed

Pharmacology for Tradename: ERYPED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
ERYPED
erythromycin ethylsuccinate
GRANULE;ORAL050207-003Mar 30, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYPED
erythromycin ethylsuccinate
GRANULE;ORAL050207-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Arbor Pharms Inc
ERYPED
erythromycin ethylsuccinate
TABLET, CHEWABLE;ORAL050297-003Jul 5, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Novartis
Accenture
Express Scripts
QuintilesIMS
Cipla
Dow
Healthtrust
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot